APA (7th ed.) Citation

B, H., H, L., K, J., SY, R., DK, Y., & JY, S. (2025). Sodium-glucose cotransporter-2 inhibitors and risk of autoimmune rheumatic diseases: Population based cohort study. BMJ (Clinical research ed.), 391, e085196. https://doi.org/10.1136/bmj-2025-085196

Chicago Style (17th ed.) Citation

B, Hong, Lee H, Jung K, Rhee SY, Yon DK, and Shin JY. "Sodium-glucose Cotransporter-2 Inhibitors and Risk of Autoimmune Rheumatic Diseases: Population Based Cohort Study." BMJ (Clinical Research Ed.) 391 (2025): e085196. https://doi.org/10.1136/bmj-2025-085196.

MLA (9th ed.) Citation

B, Hong, et al. "Sodium-glucose Cotransporter-2 Inhibitors and Risk of Autoimmune Rheumatic Diseases: Population Based Cohort Study." BMJ (Clinical Research Ed.), vol. 391, 2025, p. e085196, https://doi.org/10.1136/bmj-2025-085196.